Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,404.00
Bid: 12,416.00
Ask: 12,418.00
Change: 44.00 (0.36%)
Spread: 2.00 (0.016%)
Open: 12,330.00
High: 12,450.00
Low: 12,316.00
Prev. Close: 12,360.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Wall Street set for weak open on hedge fund-retail battle

Fri, 29th Jan 2021 12:22

* U.S. futures, European stocks drop 0.5-0.8%

* Dollar index eyes weekly gain

* GameStop price nearly doubles in U.S. pre-market

* Bitcoin jumps 14% after Elon Musk mention

By Carolyn Cohn

LONDON, Jan 29 (Reuters) - U.S. stock futures and European
stocks fell on Friday while the safe-haven dollar held its
ground as a Wall Street battle between hedge funds and retail
investors and a row in Europe over COVID-19 vaccine supply
cooled risk appetite.

Wall Street has been gripped by an assault by small traders
organising over online forums, such as Reddit, to force hedge
funds to reverse short positions - or bets that stocks would
fall - on companies such as GameStop and AMC
Entertainment.

The stand-off comes after central bank and government
stimulus have propelled stock markets to record highs in recent
weeks, encouraging involvement by retail investors.

"There's fear in terms of the volatility," said Derek
Halpenny, head of research for global markets at MUFG. "Specific
trades in pockets of the market can spread into the broader
market."

Shares in GameStop, AMC Entertainment and
BlackBerry plunged more than 40% on Thursday after
several online platforms imposed buying halts, but rebounded as
Robinhood and Interactive Brokers eased the restrictions on
Friday.

GameStop shares nearly doubled and AMC Entertainment was up
55% in U.S. pre-market trade.

"Any hedge fund will be carefully looking at all their
shorts after this week and regulators will look very carefully
at collective retail trading," Deutsche Bank analysts said.

S&P 500 futures recouped some ground in European
trade but were down 0.5% by 1138 GMT. Nasdaq 100 futures
fell 0.7% .

Britain's FTSE 100 index fell 0.8% and European
stocks dropped 0.7%.

VACCINE ROW

Delays in COVID-19 vaccine production have snowballed into a
spat between Britain, the European Union and drugmakers over how
best to direct limited supplies.

AstraZeneca offered eight million more doses of its
COVID-19 vaccine to the European Union, after it unexpectedly
announced cuts in supplies last week. But the bloc said that was
far short of what was originally promised, an EU official told
Reuters on Friday.

New variants of the novel coronavirus have also prolonged
lockdowns and delayed expectations of an economic rebound.

Barclays analysts, however, said that "institutional
positioning is not aggressive overall, and as long as vaccines
work and central banks stay put, buy-the-dip mentality should
continue".

Click here http://tmsnrt.rs/2EmTD6j for an interactive chart
on the vaccine race

The U.S. dollar rose to its highest since mid-November
against the yen, and was steady against an index of
currencies, bringing its weekly rise to 0.4%. The euro
edged up 0.1% and the pound was steady.

Bitcoin jumped as much as 14% to a two-week high
after Tesla Inc TSLA.O chief Elon Musk tagged the cryptocurrency
in his Twitter biography.

French 10-year government bond yields, which
move inversely to price, rose four basis points after France's
gross domestic product contracted less than expected in the
fourth quarter of 2020.

World stocks fell 0.4% towards three-week
lows set in the previous session, and were heading for a weekly
fall of more than 2%.

MSCI's broadest index of Asia-Pacific shares outside Japan
fell 1%, on course for a weekly loss of 4.4%.
Japan's Nikkei fell 1.9%, recording its first weekly
loss of the year.

The People's Bank of China (PBOC) injected 100 billion yuan
into the financial system on Friday, following a week of
reducing liquidity, which had sparked concerns the central bank
was in fact tightening monetary policy.

The extra money did little to loosen short-term money
markets, where rates rose for a fifth straight day and benchmark
overnight repo rates surged to their highest in
nearly six years.

Oil prices rose within recent ranges, with concerns caused
by the new coronavirus variants and slow vaccine rollouts
offsetting a cut in Saudi Arabian oil supply and falling U.S.
oil inventories.

Brent crude futures were up 0.88% at $56.02 a barrel
and U.S. crude futures rose 0.5% to $52.60 a barrel.

Gold benefited from demand for safer assets, rising
1.1%.

(Additional reporting by Tom Westbrook in Singapore and Alwyn
Scott in New York; Editing by Richard Pullin, Ana Nicolaci da
Costa, William Maclean, Larry King)

More News
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.